Understanding these mechanisms opens avenues for therapeutic interventions targeting STING trafficking in inflammatory diseases like SAVI, SLE, and COPA syndrome. This evidence concerns the gene STING1 and autoimmune interstitial lung disease-arthritis syndrome.